Renicard 50 mg FC tablets
PDF Leaflet Revision Date: 29 July 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension and renal protection in type 2 diabetic patients.
Dosage (summary)
50 mg once daily; may increase to 100 mg based on response.
Onset of Action / Duration
Onset: 3-6 weeks, Duration: Not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; can cause fetal harm.
Key Drug Interactions
- Potassium-sparing diuretics
- NSAIDs
- Fluoroquinolones
Contraindications
- Hypersensitivity
- Angioedema history
- Severe renal impairment
- Bilateral renal artery stenosis
Common side effects
- Headache
- Dizziness
- Cough
- Hyperkalaemia
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any signs of angioedema
Serious warnings
- Risk of hypotension
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Renicard 50 mg FC tablets professional information leaflet below is the property of Unichem Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
